Publicaciones (40) Publicaciones de María Encarnación Fernández Contreras

2023

  1. Effect of Lactobacillus kefiri, in Conjunction with PENS T6 and a Hypocaloric Diet, on Weight Loss, Hypertension and Laboratory Glycemic and Lipid Profile

    Nutrients, Vol. 15, Núm. 21

2019

  1. Implicación del sustrato del receptor de Insulina-4 (IRS-4) en la invasividad del cáncer colorrectal

    Séptimas Jornadas de Jóvenes Investigadores de la Universidad de Alcalá: Ciencias e Ingenierías

2018

  1. Overexpression of insulin receptor substrate-4 is correlated with clinical staging in colorectal cancer patients

    Journal of Molecular Histology, Vol. 49, Núm. 1, pp. 39-49

2017

  1. Overexpression of insulin receptor substrate-4 is correlated with clinical staging in colorectal cancer patients

    Journal of Molecular Histology, Vol. 49, Núm. 1, pp. 39-49

  2. Ratio of Circulating Estrogen Receptors Beta and Alpha (ERβ/ERα) Indicates Endoscopic Activity in Patients with Crohn’s Disease

    Digestive Diseases and Sciences, Vol. 62, Núm. 10, pp. 2744-2754

2014

  1. Influence of the IL17A locus in giant cell arteritis susceptibility

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 9, pp. 1742-1745

  2. The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: Serial observations in 37 patients

    Inflammatory Bowel Diseases, Vol. 20, Núm. 4, pp. 695-702

2013

  1. Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease

    Journal of Crohn's and Colitis, Vol. 7, Núm. 11

2012

  1. Association of thymidylate synthase and hypoxia inducible factor-1alpha DNA polymorphisms with pancreatic cancer

    Tumori, Vol. 98, Núm. 3, pp. 364-369

2011

  1. Identification of prognostic factors in pancreatic cancer

    Cirugia y Cirujanos, Vol. 79, Núm. 4, pp. 338-348

  2. Laryngeal metastasis as first presentation of hepatocellular carcinoma

    Revista Espanola de Enfermedades Digestivas

2010

  1. Impacto de los niveles preoperatorios de hemoglobina y albúmina en la supervivencia del carcinoma de páncreas

    Revista Espanola de Enfermedades Digestivas, Vol. 102, Núm. 11, pp. 631-636

  2. Influence of thymidylate synthase DNA polymorphisms and gender on the clinical evolution of patients with advanced colorectal cancer

    Oncology Reports, Vol. 23, Núm. 5, pp. 1393-1400

  3. Role of intratumoral lymphatic vessels in the lymph node dissemination of laryngopharyngeal squamous cell carcinoma

    Head and Neck, Vol. 32, Núm. 6, pp. 757-762

2009

  1. Combination of polymorphisms within 5′ and 3′ untranslated regions of thymidylate synthase gene modulates survival in 5 flourouracil-treated colorectal cancer patients

    International Journal of Oncology, Vol. 34, Núm. 1, pp. 219-229

  2. Polymorphisms in the hypoxia inducible factor 1-α and the impact on the prognosis of early stages of oral cancer

    Annals of Surgical Oncology, Vol. 16, Núm. 8, pp. 2351-2358

2007

  1. Intratumoral lymphatic vessels and VEGF-C expression are predictive factors of lymph node relapse in T1-T4 N0 laryngopharyngeal squamous cell carcinoma

    Annals of Surgical Oncology, Vol. 14, Núm. 1, pp. 248-257

2006

  1. Thymidylate synthase expression pattern, expression level and single nucleotide polymorphism are predictors for disease-free survival in patients of colorectal cancer treated with 5-fluorouracil

    International Journal of Oncology, Vol. 28, Núm. 5, pp. 1303-1310

2005

  1. P-cadherin expression reduced in squamous cell carcinoma of the oral cavity: An indicator of poor prognosis

    Cancer, Vol. 103, Núm. 5, pp. 960-969

2004

  1. Thymidylate synthase expression pattern is a prognostic factor in patients of colorectal cancer treated with 5-fluorouracil.

    International journal of oncology, Vol. 25, Núm. 4, pp. 877-885